Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins and Enhanced Biosafety Requirements. Final rule.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Federal register

• Publication date

  Unknown publication date

• Fields of study

  Law, Medicine, Environmental Science

• Identifiers
  PMID 28106357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response — United States, 2025

  2025cites this paper
• Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant

  2025cites this paper
• The Temperature-Associated Effects of Rift Valley Fever Virus Infections in Mosquitoes and Climate-Driven Epidemics: A Review

  2025cites this paper
• Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia

  2024cites this paper
• Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis.

  2024cites this paper
• Select Agent Regulatory Challenges in a Patient Care Setting: Review and Recommendations

  2023cites this paper
• Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice

  2023cites this paper
• Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates

  2023cites this paper
• Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine

  2022cites this paper
• Genomic characterization of Francisella tularensis and other diverse Francisella species from complex samples

  2022cites this paper
• Genomic comparison and phenotypic profiling of small colony variants of Burkholderia pseudomallei

  2021cites this paper
• Vaccine‐related major cutaneous reaction size correlates with cellular‐mediated immune responses after tularaemia immunisation

  2021cites this paper
• Biosafety in DIY‐bio laboratories: from hype to policy

  2021cites this paper
• Development of Immunoassays for Detection of Francisella tularensis Lipopolysaccharide in Tularemia Patient Samples

  2021cites this paper
• MAVS mediates a protective immune response in the brain to Rift Valley fever virus

  2021cites this paper
• Differences in Blood-Derived Francisella tularensis Type B Strains from Clinical Cases of Tularemia

  2020cites this paper
• The Francisella tularensis Polysaccharides: What Is the Real Capsule?

  2020cites this paper
• Differentiation of Francisella tularensis Subspecies and Subtypes

  2020cites this paper
• Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in Tissues

  2019cites this paper
• Post-exposure treatments for Ebola and Marburg virus infections

  2018cites this paper
• Large-scale protein function prediction using heterogeneous ensembles

  2018cites this paper
• Detecting Biothreat Agents: From Current Diagnostics to Developing Sensor Technologies.

  2018cites this paper
• Rift Valley fever vaccines: current and future needs.

  2018cites this paper
• Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements

  2017cites this paper
• Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus Burkholderia

  2017cites this paper
• Symptomatic reversal of botulism by aminopyridines

  year unknowncites this paper